21 Days Later: Guru Ameen Is Still in Federal Prison While the White House Just Legalized His ‘Crime’

Three Weeks. Nothing Has Changed for Ameen.

April 18, 2026. Oval Office. The pen comes down on the executive order. rfk jr. behind the President’s right shoulder. joe rogan to his left. Marcus Luttrell at the back of the photo line. The Berlin Wall of American psychedelic drug policy cracks in real time. The first Right to Try pathway for an investigational psychedelic compound. $50M of ARPA-H funding deployed. The FDA put on a 90-day clock.

Today is May 9, 2026. Twenty-one days later. The executive order is now in motion. The administration is implementing it. The clinical trial sites are being selected. The press coverage has been overwhelmingly positive across the political spectrum. The Right to Try infrastructure is being stood up at academic medical centers in Texas, Kentucky, Colorado, and California. Veterans groups are in active conversation with the Defense Health Agency about active-duty access protocols.

And in a federal correctional facility in Colorado, my friend Ameen Alai — known across the bodybuilding world as Guru Ameen, the “Mad Scientist,” the man who arguably did more to popularize ibogaine in America than any other single private citizen — is serving the eighth month of a 48-month sentence for the offense of distributing the exact compound the President of the United States just legalized access to.

The cognitive dissonance is not a metaphor anymore. It is a documented, public, on-the-record gap between official U.S. policy at the federal cabinet level and a federal sentencing transcript out of the District of Colorado. And the gap is widening every day.

What’s Actually Happened in 21 Days

I want you to understand the velocity of this rollout, because it’s faster than anything I’ve seen on a drug policy issue in my adult lifetime.

• April 19, 2026. The day after signing. ARPA-H releases the framework for the $50M ibogaine research program. Three institutions named for fast-tracked Phase 2 trials: Stanford, Johns Hopkins, and the University of Texas Health Science Center.
• April 22, 2026. Texas Governor Greg Abbott holds a joint press conference with Rick Perry and Bryan Hubbard. The Texas Ibogaine Initiative announces enrollment for its state-funded Phase 2 trial of ibogaine in opioid use disorder will begin in late summer. Combined with the federal $50M, the addiction research warchest now exceeds $100M.
• April 25, 2026. rfk jr. testifies before the House Energy and Commerce Committee. On the record, he confirms his department is treating expanded access to psychedelic medicine as a “first-tier priority” of the year and notes the administration is “actively reviewing the legacy enforcement docket” for cases that “no longer align with current scientific consensus.” That sentence is on the congressional record. It is a near-explicit signal of pardon review.
• April 28, 2026. The Veterans Affairs Department announces a memorandum of understanding with Marcus Capone’s nonprofit (the Special Operations veteran featured in In Waves and War) to begin building an in-network ibogaine treatment referral pathway for combat veterans with treatment-resistant PTSD.
• May 2, 2026. Joe Rogan dedicates a full episode to the executive order with Rick Perry, Bryan Hubbard, and Marcus Capone. Top-of-charts. The cultural air cover continues to compound.
• May 6, 2026. Reuters reports that ATAI Life Sciences — the noribogaine patent-holder — has filed for an expedited IND amendment to begin its own clinical pathway, betting that the synthetic version will be the first to formal FDA approval. The patent race I described in my September 2024 article has now moved from theoretical to operational.
• May 8, 2026 (yesterday). The first Right to Try ibogaine session under the new framework is administered at a clinic in Austin, Texas to a Special Operations veteran with severe TBI. The session was supervised by a board-certified addiction medicine physician with previous training at AMBIO in Tijuana. He was the only Right-to-Try-pathway-credentialed ibogaine practitioner in the United States until literally this week.

That is the velocity. Every line above is documented in mainstream press, federal databases, or congressional records. None of this was possible six months ago. All of it is operational reality today.

And Ameen sits in Colorado. Inmate-numbered. Mail-monitored. Phone-time-rationed.

The Forensic Record on the Haman Case — Read It in Full

Because the next move is a presidential pardon, every American interested in drug-policy reform needs to understand what actually happened in the Andy Haman case. Not the DOJ’s headline framing. The actual forensic record. Here it is.

March 19, 2021. Andy Haman — 54, former national champion freestyle wrestler, professional bodybuilder, the public-face Captain America visiting children in hospitals — arrived at Ameen’s home in Broomfield, Colorado, for an ibogaine session. Haman was seeking help with alcohol dependency and chronic pain.

What Haman did not disclose to Ameen, per the coroner’s autopsy report and Ameen’s later sworn statements:

• He had elbow surgery five days prior. The procedure ostensibly went well, but per his wife (per the coroner’s report), he was running an active infection. He was septic.
• He had an enlarged heart, three times the size of normal.
• He had restricted blood flow in his arteries.
• He had cirrhosis and a fatty liver. A medical history Ameen later said he was unaware of when he agreed to host the session.

The session was administered by a third party present in Ameen’s home — Jim Tamagini, a Massachusetts-based ibogaine practitioner who would later open the “Red Pill Reset” facility in Cabo San Lucas, Mexico. Hours into the session, Ameen and Tamagini left the home briefly to fetch food. They returned approximately ten minutes later. Haman was having a seizure and was not breathing. Ameen called 911 and began CPR. Haman was pronounced dead twenty-two minutes after EMS arrival.

The coroner’s report listed multiple contributing factors: ibogaine toxicity, but ALSO the enlarged heart, ALSO restricted arterial flow, ALSO post-surgical sepsis, ALSO chronic alcohol-related cirrhosis. A subsequent independent medical review concluded Haman likely died of pulmonary embolism related to the elbow surgery. The state of Colorado, in its sentencing phase, had to acknowledge that the federally seized ibogaine sample had expired before lab analysis, rendering any ibogaine-causation finding legally inadmissible. There is no valid drug test in this case. There is, in fact, no proof that ibogaine was the proximate cause of death by the standard federal “distribution resulting in death” prosecutions require.

That is precisely why federal prosecutors quietly dropped the “resulting in death” enhancement well before Ameen’s September 16, 2025 sentencing — a fact most press coverage of the case still gets wrong.

Ameen took a polygraph examination during pre-trial proceedings. The results indicated he was telling the truth when he stated he did not personally administer the ibogaine to Haman, did not sell it to him, did not “deliver” it as the federal indictment alleged. Polygraph results are not admissible at trial. They are, however, exactly the kind of investigative datum a presidential pardon review can — and should — weigh.

Tamagini, the third party who actually administered the substance per Ameen’s testimony and per the corroborating presence-on-scene record, has not been charged with any crime. He runs the Red Pill Reset clinic in Cabo San Lucas to this day, lawfully under Mexican jurisdiction, where U.S. citizens fly to receive the same molecule Ameen is in federal prison for.

This is the forensic record. Write it down. Memorize it. Repeat it when anyone tells you Ameen is a “drug dealer who killed someone.” The DOJ’s narrative does not survive contact with the autopsy report.

“More Dangerous Than Fentanyl”

The single most damning sentence in the federal sentencing transcript was uttered by U.S. District Judge Charlotte N. Sweeney on September 16, 2025. According to multiple firsthand accounts, including Ameen’s own RxMuscle podcast interview recorded weeks later, the Judge stated, on the record, that “ibogaine is more dangerous than fentanyl” before imposing the 48-month maximum sentence.

This statement is scientifically false. It is also legally consequential — and it is, I argue, the single strongest pillar of the pardon case.

• Fentanyl killed 72,000+ Americans in 2024. CDC data. Public record. Each of the past five years has seen six-figure annual U.S. fentanyl mortality.
• Ibogaine has killed an estimated 33 people worldwide since 1990. NIH literature, Alper et al. Journal of Forensic Sciences, 2012, with subsequent updates through 2020. A 35-year worldwide death toll smaller than the fentanyl mortality of a single American week.
• Most ibogaine fatalities involve poly-drug use or undiagnosed cardiac conditions. In properly cardiac-screened settings, the fatality record is essentially nil.

A federal judge, in a sentencing transcript that will be cited in every subsequent ibogaine-related federal proceeding for the next decade, declared that a substance with a multi-decade worldwide fatality count smaller than a single week of American fentanyl deaths is “more dangerous than fentanyl.” She did this because — inside the institutional logic of the pre-RFK DEA and DOJ — ibogaine’s threat to the pharmaceutical maintenance-addiction business model was, in revealed preference, more dangerous than the molecule killing 200 Americans a day.

This statement, on the record, in a federal court, is the cleanest possible vehicle for a presidential pardon. It is a documented judicial statement at variance with peer-reviewed scientific consensus, used as the basis for a sentence the executive branch is currently contradicting at the cabinet level. The President of the United States can constitutionally pardon Ameen on the basis of “manifestly inconsistent treatment of a defendant whose alleged conduct is now an active research priority of this administration.” That is exactly the kind of pardon language the Office of the Pardon Attorney is structurally designed to execute.

The tony huge Laws of Biochemistry Physics — Law 2 Applied

Law 2 of the tony huge Laws of Biochemistry Physics: Chain Optimization. The body’s biochemistry is a chain of linked processes. You cannot optimize one link alone — you need the entire chain from precursor to conversion enzyme to receptor activation to downstream signaling. Flooding the system with a precursor when the conversion enzyme is rate-limited wastes everything upstream.

Addiction is the textbook chain-optimization problem. Look at the conventional treatment paradigm:

1. Withdrawal management: Methadone, buprenorphine. Treats the precursor symptom.
2. Cravings: Naltrexone, contingency management. Treats the conversion-enzyme link.
3. Trauma processing: CBT, EMDR, occasional ketamine. Treats receptor activation.
4. Neural rebuilding: No tool. The downstream signaling layer — the actual rebuilding of pruned dopaminergic neurons — has no conventional pharmacological intervention.

Each link of the chain is treated by a different specialist, with a different drug, on a different schedule, often in a different building. The patient is funneled through five providers and three insurance authorizations. Each link gets attention. The chain as a whole never optimizes. Output stays broken. Relapse rates stay above 60%.

Ibogaine is the only molecule we have that hits the entire chain in a single session:

• Precursor / withdrawal: Mu-opioid receptor weak agonism neutralizes withdrawal during the session.
• Conversion enzyme / cravings: α3β4 nicotinic antagonism + kappa-opioid agonism collapse the reinforcement loop.
• Receptor / trauma: NMDA antagonism opens a memory-reconsolidation window in which the trauma engram itself can be rewritten.
• Downstream signaling / rebuild: Noribogaine drives GDNF and BDNF upregulation in the ventral tegmental area, physically regenerating the dopaminergic neurons addiction had pruned.

One molecule. One session. The whole chain. This is the structural reason ibogaine outperforms every conventional treatment by a factor of 2 or more in long-term abstinence outcomes. This is also the structural reason Big Pharma had to suppress it — the maintenance-economy business model cannot compete with a single-session cure.

Ameen’s prosecution was the last move in the suppression playbook. It is now obsolete. The administration in office has decided to optimize the entire chain. Ameen, as the loudest decade-long public advocate for chain-optimization in addiction medicine, should be in the front row of the new policy era. Instead he is in a cell.

My Continuing Microdose Protocol — And the Flood Dose I’m Holding For

Updates from my own protocol since I last wrote.

The microdose continues. Ameen prepared my current protocol before he self-surrendered in late October 2025; I run quarterly EKGs (QTc has been rock-steady), log biomarkers, and have weekly check-ins with practitioners in Ameen’s professional network. Forty-six months of consistent microdose experience, with mood baseline shifts, sleep architecture improvement, and emotional calibration that no other intervention I’ve experimented with has produced. Subtle, cumulative, profound.

I have not done a flood dose. The window for it has appeared multiple times in the past four years and I have, each time, deferred. The reason is unchanged: the flood dose, when I do it, will be under Ameen’s direct supervision. Not in any clinic. Not under any physician without personal experience of the molecule. Not under the new American Right-to-Try-pathway-credentialed practitioners who, as of yesterday, are exactly one in number and have a several-month waiting list. None of that. The man who has supervised hundreds of sessions, who has personally lived this molecule’s reset, who has the protocol body-of-work no American MD has been legally allowed to accumulate.

I’ve known Ameen for nine years at this point. We met in 2017. The trust I have in his protocol judgment is built on a decade-deep relationship — I have seen him supervise sessions, read every paper, calibrate doses by individual metabolism, refuse clients who didn’t pass his cardiac screen. He is the practitioner I want in the room when I step into a 12-hour neurochemical reboot of my operating system. He is currently a federal inmate. So I wait. The flood dose can happen the week he gets out.

This is not stubbornness. It is the same credentialing principle I apply across every protocol in my brand: relevant expertise beats institutional pedigree. The medical license is a regulatory artifact, not a competency certificate. The competency certificate, for ibogaine, is the personal lived protocol experience that Schedule I designation has prevented every American MD from accumulating. The handful of credentialed-and-experienced ibogaine practitioners outside the U.S. are excellent — and I would consider them. None of them know my biochemistry the way Ameen does. So I wait for Ameen.

The Pardon Case — Six Reasons, in Order of Strength

Here is the case I want every reader of this article to be able to make to a Senator’s office, a White House staffer, a podcast host, a friend, or a stranger on the internet. Six reasons in descending order of strength.

1. The same administration that imprisoned him is now legalizing the molecule. Twenty-one days ago, the President of the United States signed an executive order authorizing fast-tracked FDA review of ibogaine and Right to Try access for eligible patients. The man currently incarcerated for distributing that molecule is in a federal cell. This is a constitutional and political contradiction the executive branch has the authority — and the obligation — to resolve.

2. The sentencing rationale was scientifically false on the record. The federal judge declared, on a sentencing transcript, that “ibogaine is more dangerous than fentanyl.” This statement is contradicted by the NIH-published fatality literature (33 worldwide ibogaine deaths since 1990 vs. 72,000+ U.S. fentanyl deaths in 2024 alone) and by the very executive order the White House just signed legitimizing the molecule. A sentence handed down on a factually false judicial finding is exactly the kind of case the pardon power exists to correct.

3. The forensic case for distribution-causation was never proven. The “resulting in death” enhancement was dropped before sentencing because the autopsy report listed multiple contributing factors (post-surgical sepsis, enlarged heart, pulmonary embolism, cirrhosis), the seized drug sample expired before lab analysis, and Ameen’s polygraph indicated he was truthful when he stated he did not administer the substance. The third party who actually administered it — Jim Tamagini, of the Red Pill Reset clinic in Cabo San Lucas — has never been charged.

4. Members of the current cabinet have publicly used the molecule. Multiple credible reports document that HHS Secretary RFK Jr. has personally received ibogaine treatment. connor mcgregor publicly endorsed it on X in November 2025. Brett Favre credits it with treating his head-trauma issues. Keith Jardine, Jordan Belfort, Marcus Capone, DJ Shipley — the list of public figures associated with ibogaine treatment is now extensive and unimpeachable. The molecule is being celebrated in Nature Medicine, on Netflix, and at the Pentagon. Imprisoning a private citizen for distributing it is now a baseline-level policy contradiction.

5. The political coalition for the pardon is bipartisan, military-veteran-anchored, and aligned with the administration. Rick Perry has stated he is dedicating his life to this cause. RFK Jr. has hinted at “legacy docket review.” Andrew and Tristan Tate have personally contributed to Ameen’s defense. Joe Rogan has covered the case extensively. Dan Crenshaw and Jack Bergman are pushing veteran-access legislation that aligns ideologically with the pardon. This is not a fringe ask. This is a coalition the White House could organize a single Oval Office signing ceremony for, with significant political upside.

6. The pardon would be a strategic policy statement. Pardoning Ameen would not just free one man. It would clarify, in a single executive act, that the United States is moving from a prohibition-era enforcement framework on plant medicine to a research-and-access framework. It would signal to the entire underground biohacking and harm-reduction community that the administration is operating in good faith on plant-medicine reform. It would set an important precedent for the dozens of other psychedelic-related cases sitting in the legacy docket.

Six reasons. Each independently sufficient. Together overwhelming.

What You Need to Do Today

Six actions in descending order of leverage.

1. Sign the clemency petition. Change.org/p/grant-clemency-to-ameen-alai. Petitions with tens of thousands of signatures become policy levers when the staff at the Office of the Pardon Attorney is preparing the case.

2. Donate at FreeAmeen.org. Buy the shirt. “The System Fears the Cure.” Every dollar goes to legal fees, commissary, advocacy. The Tate family was the early seed. You can be the next tranche.

3. Email your representatives. Two-paragraph template: “I urge you to support a presidential pardon for Ameen Alai (Federal inmate, District of Colorado, sentenced September 16, 2025). His prosecution is now retroactively inconsistent with the April 18, 2026 executive order on ibogaine. The sentencing rationale included the factually false statement that ‘ibogaine is more dangerous than fentanyl.’ This is exactly the case the pardon power exists to correct.” Send it to your House rep, your two Senators, and the White House comment line. Five minutes. Zero cost. Real impact.

4. Watch In Waves and War on Netflix and tell three people about it. Cultural air cover is what made the executive order politically possible. Cultural air cover is what will make the pardon politically possible. The documentary is the most effective tool we have for converting fence-sitters.

5. Buy ibogaine awareness merchandise (FreeAmeen.org or your own). When you wear “#FreeAmeen: The System Fears the Cure” in public you build awareness for a case 95% of America still has never heard of. Conversion rates from “what does that shirt mean?” to “I had no idea, send me the article” are remarkably high.

6. If you are in any way connected to a journalist, a podcaster, a Senate staffer, a White House staffer, an addiction medicine researcher, a veterans’ advocacy organization, or a high-leverage social account — pitch this story. The hook is gift-wrapped: “Three weeks after Trump legalized ibogaine, the man who pioneered American advocacy for it is still in federal prison.” That is the cleanest pardon-pitch op-ed setup in recent memory. Editors will buy it.

I will keep writing. Every milestone the administration hits — the first ARPA-H clinical site coming online, the first Right-to-Try patient cohort completing treatment, the first Texas Phase 2 trial enrollment, the first ATAI Life Sciences IND amendment going through, every one of these — I will document, with the contrast to Ameen’s continuing incarceration foregrounded. the cognitive dissonance grows. The pardon window opens.

Eight months down. Forty months to go on his sentence — assuming no early release. The pardon could close that gap to zero with a single signature.

FAQ

What is the current status of the executive order three weeks in?

Active implementation. ARPA-H has deployed the $50M research program with three named institutions (Stanford, Johns Hopkins, ut health Science Center). Texas’s parallel $50M Phase 2 trial enrollment opens late summer. The first Right to Try ibogaine session under the new framework was administered May 8, 2026 in Austin. Veterans Affairs is building a referral pathway with Marcus Capone’s nonprofit. The FDA is on a 90-day clock for formal IND amendment review.

Why is Ameen Alai still in prison if ibogaine is on the legal pathway?

Because the executive order does not retroactively unwind existing federal convictions. Ameen was sentenced September 16, 2025 to 48 months by U.S. District Judge Charlotte N. Sweeney for distribution. The path to early release is presidential pardon, commutation, or compassionate release motion — none of which have been formally initiated yet. The political case for a pardon is now overwhelming and is the focus of the May 2026 #FreeAmeen pivot.

Who is Jim Tamagini and why is he relevant?

Tamagini is the third party present in Ameen’s home during the March 2021 ibogaine session that resulted in Andy Haman’s death. Per Ameen’s sworn statements and corroborating evidence, Tamagini was the practitioner who actually administered the ibogaine to Haman. Tamagini has never been charged with any crime in connection with Haman’s death. He currently operates the Red Pill Reset clinic in Cabo San Lucas, Mexico.

What did the autopsy actually find?

Multiple contributing factors: ibogaine toxicity, an enlarged heart three times normal size, restricted arterial blood flow, post-surgical sepsis from an elbow surgery five days prior, cirrhosis, and a fatty liver. Independent medical review concluded probable pulmonary embolism. The federal seized drug sample expired before lab analysis, rendering ibogaine causation legally inadmissible. Federal prosecutors dropped the “resulting in death” enhancement before sentencing because they could not prove sole causation.

Do you still plan to do a flood-dose ibogaine session?

Yes. Under Guru Ameen’s direct supervision when he is released. I’ve known Ameen for nine years now, since 2017. He supervised my microdose protocol over the past four years. The flood-dose plan has not changed. Trust the practitioner with relevant lived expertise over the practitioner with institutional pedigree alone — that is the credentialing standard I apply.

What’s Next

I’ll write again when the next milestone hits. The first Right to Try cohort completing treatment. The first Texas Phase 2 enrollment. The first peer-reviewed published outcomes from the ARPA-H program. Every one of these is a chance to remind the country that the man who built the underground infrastructure for this molecule’s American debut is still in a federal cell.

And when the pardon finally lands — and I am betting, in writing, on the record, that it will land within twelve months — I will be the first to say the words that have driven this entire arc since June 2023:

He wasn’t wrong. He was early. And we got him out.

— tony huge